0001104659-21-130370.txt : 20211027
0001104659-21-130370.hdr.sgml : 20211027
20211027124630
ACCESSION NUMBER: 0001104659-21-130370
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211027
DATE AS OF CHANGE: 20211027
EFFECTIVENESS DATE: 20211027
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyprium Therapeutics, Inc.
CENTRAL INDEX KEY: 0001890689
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-418723
FILM NUMBER: 211351915
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
D
1
primary_doc.xml
X0708
D
LIVE
0001890689
Cyprium Therapeutics, Inc.
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
NEW YORK
10014
781-652-4500
DELAWARE
None
None
Corporation
true
Lung
Yam
2 Gansevoort Street
9th Floor
New York
NY
NEW YORK
10014
Executive Officer
Lindsay
A.
Rosenwald
2 Gansevoort Street
9th Floor
New York
NY
NEW YORK
10014
Director
Other Health Care
No Revenues
- 06b
false
2020-07-27
false
true
false
25000
National Securities Corporation
7569
None
None
20 VESEY STREET, 25TH FLOOR
NEW YORK
NY
NEW YORK
10281
All States
false
7000000
7000000
0
false
75
870000
0
0
false
Cyprium Therapeutics, Inc.
/s/ Lung S. Yam, M.D., Ph.D.
/s/ Lung S. Yam, M.D., Ph.D.
Chief Executive Officer
2021-10-05